|
抗磷脂综合征的研究进展 |
| |
sp;are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature ［J］. Blood, 2003, 101 (5): 1827-1832.
［6］ HWANG K, GROSSMAN JM .V ISVANATHAN S. et al. Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin ［J］. Immunol, 2001, 167 (12): 7192-7198.
［7］ JIANWEI ZHANG, AND KEITH R. MCCRAE .Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-B2 glycoprotein I antibodies ［J］. Blood, 2005, 105 (5): 1964-1969.
［8］ RAND JH，wu XX，QUINN AS, et al. Human monoclonal antiphospholipid antibodies disrupt the annexina5 anticoagulant crystal shield on phospholipids bilayers：evidence from atomic force microscopy and functional assay ［J］.Am J Pathol,2003,163 (3):1193-l200.
［9］ ZHANG J, MCCRAE KR. AnnexinA2 mediates endothelial cell activation by antiphospholipid/antibeta2glycoprotein antibodies ［J］.Blood,2005, 105 (5):1964-1969.
［10］ ZHOU H, WOLBERG AS, ROUBEY RA. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep ［J］. Blood, 2004, 104 (8):2353-2358.
上一页 [1] [2] [3] [4] [5] [6] 下一页
上一个医学论文： 上肢深静脉血栓形成的临床特征 附14例分析
下一个医学论文： 获得性血管性血友病的研究进展
|
|
|
|
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文